Collyer Law LLC advised a venture capital fund on its investment in the Series A fundraising round of a synthetic biotechnology start-up that develops livestock disease prevention biotechnology. The start-up offers recombinant custom peptides cultivated using synbio microorganisms as an antibiotic replacement for disease prevention and growth promotion in livestock, providing breeders and farmers with humane, sustainable, highly productive agriculture without the use of antib

Collyer Law advised Betatron Ventures in relation to its investment in Botsync, a Singapore-based autonomous robotics startup, during its...

Collyer Law LLC advised AI Palette on its US$5.8M Series A1 financing from Tin Men Capital, Exfinity Ventures and Pi Ventures. Ai Palette...

Collyer Law advised 500 Startups, a venture capital firm with a Singapore office, in relation to its investment in the US$2.1 million...

Collyer Law LLC advised 500 Startups in relation to its exit for an undisclosed amount from BizziBots Pte. Ltd. to Do Ventures as part of...